Choate recently represented Symbiotix Biotherapies, Inc. (Symbiotix), a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome, in its recent equity financing from…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
